BMD response to Teriparatide in treatment naive patients versus patients previously treated with a bisphosphonate

被引：0
|
作者：
File, E. A. [1 ]
Deal, C. L. [1 ]
Butler, R. S. [1 ]
机构：
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2007年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
T367
引用
收藏
页码：S323 / S323
页数：1
相关论文
共 50 条
  • [1] Patient Characteristics and Fracture Outcomes in Patients Previously Treated With Bisphosphonates or Treatment-naive in the Teriparatide versus Risedronate VERO Clinical Trial
    Hadji, Peyman
    Marin, Fernando
    Kendler, David
    Geusens, Piet
    Russo, Luis
    Malouf, Jorge
    Lakatos, Peter
    Minisola, Salvatore
    Lopez-Romero, Pedro
    Fahrleitner-Pammer, Astrid
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 286 - 286
  • [2] The relationship between P1NP and BMD in patients receiving Teriparatide post bisphosphonate treatment
    Kapoor, Sabrina R.
    Fraser, William D.
    Marks, Eileen
    Ismail, Abbas A.
    [J]. RHEUMATOLOGY, 2008, 47 : II169 - II169
  • [3] Responses to Treatment With Teriparatide in Patients With Atypical Femur Fractures Previously Treated With Bisphosphonates
    Watts, Nelson B.
    Aggers, Deborah
    McCarthy, Edward F.
    Savage, Tina
    Martinez, Stephanie
    Patterson, Rachel
    Carrithers, Erin
    Miller, Paul D.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (05) : 1027 - 1033
  • [4] Effects of denosumab versus teriparatide in glucocorticoid-induced osteoporosis patients with prior bisphosphonate treatment
    Hirooka, Yasuaki
    Nozaki, Yuji
    Inoue, Asuka
    Li, Jinhai
    Shiga, Toshihiko
    Kishimoto, Kazuya
    Sugiyama, Masafumi
    Kinoshita, Koji
    Funauchi, Masanori
    Matsumura, Itaru
    [J]. BONE REPORTS, 2020, 13
  • [5] An algorithm using the early changes in PINP to predict the future BMD response for patients treated with daily teriparatide
    R. Niimi
    T. Kono
    A. Nishihara
    M. Hasegawa
    A. Matsumine
    T. Nakamura
    T. Kono
    A. Sudo
    [J]. Osteoporosis International, 2014, 25 : 377 - 384
  • [6] An algorithm using the early changes in PINP to predict the future BMD response for patients treated with daily teriparatide
    Niimi, R.
    Kono, T.
    Nishihara, A.
    Hasegawa, M.
    Matsumine, A.
    Nakamura, T.
    Kono, T.
    Sudo, A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2014, 25 (01) : 377 - 384
  • [7] OUR EXPERIENCE AND ANALYSIS OF QUALITY OF LIFE AND CHANGES IN BMD IN PATIENTS TREATED WITH TERIPARATIDE
    Popova, V.
    Geneva-Popova, M.
    Kraev, K.
    Kartev, S.
    Popov, I.
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S140 - S141
  • [8] Differential glatiramer acetate treatment persistence in treatment-naive patients compared to patients previously treated with interferon
    Mireya Fernández-Fournier
    Antonio Tallón-Barranco
    Beatriz Chamorro
    Patricia Martínez-Sánchez
    Inmaculada Puertas
    [J]. BMC Neurology, 15
  • [9] Differential glatiramer acetate treatment persistence in treatment-naive patients compared to patients previously treated with interferon
    Fernandez-Fournier, Mireya
    Tallon-Barranco, Antonio
    Chamorro, Beatriz
    Martinez-Sanchez, Patricia
    Puertas, Inmaculada
    [J]. BMC NEUROLOGY, 2015, 15
  • [10] Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur
    S. L. Greenspan
    K. Vujevich
    C. Britton
    A. Herradura
    G. Gruen
    I. Tarkin
    P. Siska
    B. Hamlin
    S. Perera
    [J]. Osteoporosis International, 2018, 29 : 501 - 506
12345